Eisai Co., Ltd.

4523.T
Drug Manufacturers - Specialty & Generic
2026/04/03 Updated
Market Cap: $8.9B (¥1.4T)
Stock Price: $31.55 (¥5,032)
Exchange Rate: 1 USD = ¥159.49

Notice Regarding the Appointment of Director Candidates

At the Ordinary General Meeting of Shareholders scheduled for June 17, 2026, the reappointment and new appointment of director candidates will be decided. A total of 12 candidates, including 2 newly appointed outside directors, are scheduled for appointment.

Importance:
Page Updated: March 26, 2026
IR Disclosure Date: March 26, 2026

Key Figures

  • Number of Director Candidates: 12 (including reappointments)
  • Number of Newly Appointed Outside Director Candidates: 2
  • Scheduled Director Change Date: 2026-06-17

AI要約

Overview of the Appointment of Director Candidates

Eisai Co., Ltd. has decided on the director candidates to be submitted at the Ordinary General Meeting of Shareholders scheduled for June 17, 2026. The candidates total 12, including internal and outside directors, with 2 being newly appointed outside directors. Most existing directors are scheduled for reappointment, including the Chairman of the Board and chairpersons of various committees. The outside director candidates meet the requirements of the Companies Act Enforcement Regulations.

Profiles and Roles of Newly Appointed Director Candidates

The newly appointed outside director candidates are Koichi Kawana and Yuko Toyoda. Mr. Kawana has extensive management experience at JGC Corporation and serves as an outside director for multiple companies. Ms. Toyoda is a lawyer serving as a partner at a law firm and concurrently serves as an outside director for several companies. These appointments aim to strengthen governance and are expected to enhance the company's future management oversight system.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.